BDBM385067 US10287267, Compound 1085::US10287267, Compound 72::US10508099, Compound 1085::US10556885, Compound 1085::US10604514, Compound 5::US11174244, Compound 72::US11673881, Compound 72

SMILES Cn1cc(cn1)-c1ccc2cnc(NC(=O)C3CCNCC3)cc2c1

InChI Key InChIKey=YMQORBMBDCILMV-UHFFFAOYSA-N

Data  26 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 26 hits for monomerid = 385067   

LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  3nMAssay Description:Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1 Kinase buffer to final concentrations of 0.19 μg/mL, 30 μ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Biosplice Therapeutics

US Patent
LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  83nMAssay Description:The GSK3B kinase assay is run using the Ser/Thr 09 peptide Z-lyte assay kit according to manufacturer's instructions (Life Technologies-a Divisio...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Biosplice Therapeutics

US Patent
LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  64nMAssay Description:The GSK3B kinase assay is run using the Ser/Thr 09 peptide Z-lyte assay kit according to manufacturer's instructions (Life Technologies-a Divisio...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  2.40nMAssay Description:Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Biosplice Therapeutics

US Patent
LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  83nMAssay Description:The GSK3β kinase assay is run using the Ser/Thr 09 peptide Z-lyte assay kit according to manufacturer's instructions (Life Technologies a Di...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Biosplice Therapeutics

US Patent
LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  64nMAssay Description:The GSK3β kinase assay is run using the Ser/Thr 09 peptide Z-lyte assay kit according to manufacturer's instructions (Life Technologies a Di...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  2.40nMAssay Description:The DYRK1A kinase assay was run using the Ser/Thr 18 peptide Z-lyte assay kit according to manufacturer's instructions (Life Technologies a Divis...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  2.5nMAssay Description:The DYRK1A kinase assay was run using the Ser/Thr 18 peptide Z-lyte assay kit according to manufacturer's instructions (Life Technologies a Divis...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Biosplice Therapeutics

US Patent
LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  83nMAssay Description:GSK3B: This is a non-radioactive assay using fluorescence resonance energy transfer (FRET) between coumarin and fluorescein to detect kinase activity...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Biosplice Therapeutics

US Patent
LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  64nMAssay Description:GSK3B: This is a non-radioactive assay using fluorescence resonance energy transfer (FRET) between coumarin and fluorescein to detect kinase activity...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  2.40nMAssay Description:The DYRK1A kinase assay was run using the Ser/Thr 18 peptide Z-lyte assay kit according to manufacturer's instructions. This is a non-radioactive...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  2.5nMAssay Description:The DYRK1A kinase assay was run using the Ser/Thr 18 peptide Z-lyte assay kit according to manufacturer's instructions. This is a non-radioactive...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Biosplice Therapeutics

US Patent
LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  115nMAssay Description:Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1 Kinase buffer to final concentrations of 0.04 μg/mL, 46 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  2.5nMAssay Description:Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Biosplice Therapeutics

US Patent
LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  83nMAssay Description:Each compound is dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves f...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Biosplice Therapeutics

US Patent
LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  64nMAssay Description:Each compound is dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves f...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  2.40nMAssay Description:Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  2.5nMAssay Description:Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  2.20E+3nMAssay Description:SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  920nMAssay Description:SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  2.5nMAssay Description:Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  2.20E+3nMAssay Description:The screening assay for Wnt activity is described as follows. Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., col...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  920nMAssay Description:The screening assay for Wnt activity is described as follows. Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., col...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Biosplice Therapeutics

US Patent
LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  83nMAssay Description:Each compound is dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves f...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Biosplice Therapeutics

US Patent
LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  64nMAssay Description:Each compound is dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves f...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM385067(US10287267, Compound 1085 | US10287267, Compound 7...)
Affinity DataEC50:  2.40nMAssay Description:Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ...More data for this Ligand-Target Pair
In DepthDetails
US Patent